United States Of America v. Novartis Pharmaceuticals Corporation

  1. March 26, 2021

    Novartis Says Chair Contradicted Admissions In FCA Deal

    Novartis said its chairman incorrectly contradicted the company's admissions that it made as part of a $678 million deal with the federal government to settle claims it flouted the False Claims Act through a kickback scheme to pump up prescriptions.

  2. July 22, 2020

    Novartis Whistleblower Scores $109M For Flagging Kickbacks

    The former Novartis Pharmaceuticals Corp. sales representative who blew the whistle on the Swiss drugmaker's alleged scheme to pump up prescriptions through kickbacks will get $109 million plus a share of the interest paid in a $629.8 million False Claims Act settlement approved this month.

  3. July 01, 2020

    Novartis To Pay $729M To End 2 FCA Kickback Accusations

    Novartis Pharmaceuticals Corp. has agreed to pay more than $729 million to end two separate sets of allegations from the U.S. Department of Justice that it violated the False Claims Act through companywide kickback schemes to pump up prescriptions, the agency said Wednesday.

  4. June 21, 2019

    Biggest Health And Life Sci Rulings Of 2019: Midyear Report

    The first half of 2019 saw an extraordinary eruption of important court decisions likely to leave lasting marks on the opioid crisis, the False Claims Act, the Affordable Care Act and Medicare reimbursement. Here, Law360 takes stock of consequential health care and life sciences rulings that lawyers need to know.

  5. April 01, 2019

    DOJ's Novartis Kickback Case Cleared For Trial

    The U.S. Department of Justice has adequately described a "companywide kickback scheme" at Novartis Pharmaceuticals Corp. to pump up prescriptions, a New York federal judge said in a ruling released Monday that allows the enormous False Claims Act case to continue toward trial.

  6. August 30, 2018

    DOJ Says It Can Prove Novartis Dinners Were Kickbacks

    The U.S. Department of Justice shot back against Novartis Pharmaceuticals Corp.'s claims that extensive discovery hasn't turned up proof that the drugmaker bribed doctors to write prescriptions through its fraudulent speaker program, telling a New York federal court that the government will be able to win the case.

  7. March 29, 2017

    Feds Win Extra Event Docs In Novartis Kickbacks Suit

    Novartis Pharmaceuticals Corp. must give the government documents from more than 72,000 dinners and other events that may have served as illegal kickbacks to doctors, a New York federal judge said Tuesday, ending a nearly yearlong debate over whether that was a fair expansion of an original discovery agreement.

  8. April 07, 2016

    Novartis, Feds Ordered To Hash Out Kickbacks Discovery

    A New York federal judge on Thursday ordered Novartis Pharmaceuticals Corp. and government attorneys to straighten out a miscommunication over whether paperwork from more than 72,000 dinners and other events that may have served as illegal kickbacks to doctors were part of their original discovery agreement.